Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)

PHASE3CompletedINTERVENTIONAL
Enrollment

844

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2014

Study Completion Date

May 31, 2015

Conditions
Latent Tuberculosis Infection
Interventions
DRUG

Isoniazid

The dosage of the medication is determined according to the weight of the child. The dose is once per day, 10-15 mg/kg/day (max=300mg/day). Total duration of treatment is 9 months. Both a detailed dose chart calculating doses by weight and age and protocols for preparation of medications (crushing pills, mixing suspensions) are available.

DRUG

Rifampin

The dosage of the medication is determined according to the weight of the child. The dose is once per day, 10-20 mg/kg/day (max=600mg/day). Total duration of treatment is 4 months. Both a detailed dose chart calculating doses by weight and age and protocols for preparation of medications (crushing pills, mixing suspensions) are available.

Trial Locations (9)

Unknown

Woolcock Institute of Medical Research, Sydney

Centre de Pneumophthysiologie, Cotonou

Universidade Gama Filho, Centro de Ciências Biológicas e da Saúde, Rio de Janeiro

University of Alberta, Edmonton

British Columbia Centre for Disease Control, Vancouver

Research and Development Unit, Komfo Anokye Teaching Hospital, Kumasi

Service de Pneumo-Phtisiologie, Hopital National Ignace Deen, Conakry

Health Research Unit, Faculty of Medicine, Bandung

H2X 2P4

Montreal Children's Hospital, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McGill University

OTHER

NCT00170209 - Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) | Biotech Hunter | Biotech Hunter